BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryoo GH, Moon YJ, Choi S, Bae EJ, Ryu JH, Park BH. Tussilagone promotes osteoclast apoptosis and prevents estrogen deficiency-induced osteoporosis in mice. Biochem Biophys Res Commun 2020;531:508-14. [PMID: 32807498 DOI: 10.1016/j.bbrc.2020.07.083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kou Y, Li C, Yang P, Li D, Lu X, Liu H, Li M. The W9 peptide inhibits osteoclastogenesis and osteoclast activity by downregulating osteoclast autophagy and promoting osteoclast apoptosis. J Mol Histol 2021. [PMID: 34664129 DOI: 10.1007/s10735-021-10030-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ding D, Yan J, Feng G, Zhou Y, Ma L, Jin Q. Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis. Int J Mol Med 2022;49:4. [PMID: 34738623 DOI: 10.3892/ijmm.2021.5059] [Reference Citation Analysis]
3 Lin H, Chen M, Gao Y, Wang Z, Jin F. Tussilagone protects acute lung injury from PM2.5 via alleviating Hif-1α/NF-κB-mediated inflammatory response. Environ Toxicol 2022. [PMID: 35112795 DOI: 10.1002/tox.23476] [Reference Citation Analysis]
4 Sun Y, Li J, Xie X, Gu F, Sui Z, Zhang K, Yu T. Recent Advances in Osteoclast Biological Behavior. Front Cell Dev Biol 2021;9:788680. [PMID: 34957116 DOI: 10.3389/fcell.2021.788680] [Reference Citation Analysis]
5 Shams R, Drasites KP, Zaman V, Matzelle D, Shields DC, Garner DP, Sole CJ, Haque A, Banik NL. The Pathophysiology of Osteoporosis after Spinal Cord Injury. Int J Mol Sci 2021;22:3057. [PMID: 33802713 DOI: 10.3390/ijms22063057] [Reference Citation Analysis]